NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX)

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Common Stock, Par Value $0.01 per share
Shares outstanding
162,190,120
Number of holders
394
Total 13F shares, excl. options
39,714,489
Shares change
-2,702,073
Total reported value, excl. options
$8,429,599,286
Value change
-$519,994,166
Put/Call ratio
103%
Number of buys
222
Number of sells
-177
Price
$212.31

Significant Holders of NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) as of Q2 2021

521 filings reported holding NVAX - NOVAVAX INC - Common Stock, Par Value $0.01 per share as of Q2 2021.
NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) has 394 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 39,714,489 shares of 162,190,120 outstanding shares and own 24.5% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (6,670,660 shares), FMR LLC (4,885,203 shares), BlackRock Inc. (4,555,420 shares), RA CAPITAL MANAGEMENT, L.P. (2,559,918 shares), STATE STREET CORP (1,693,390 shares), FRANKLIN RESOURCES INC (1,099,662 shares), GEODE CAPITAL MANAGEMENT, LLC (882,728 shares), CITADEL ADVISORS LLC (683,468 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (670,645 shares), and AMERIPRISE FINANCIAL INC (638,088 shares).
This table shows the top 394 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.